Sequent Scientific Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sequent Scientific Limited with three other
companies in this sector in India:
sales of 10.14 billion Indian Rupees [US$156.34 million]
Orchid Pharma Ltd
(7.97 billion Indian Rupees [US$122.82 million]
Bliss GVS Pharma Limited
(8.00 billion Indian Rupees [US$123.32 million]
of which 100%
was Pharmaceutical Business).
During the year ended March of 2017, sales at
Sequent Scientific Limited were 9.00 billion Indian Rupees (US$138.73 million).
increase of 41.8%
versus 2016, when the company's sales were 6.34 billion Indian Rupees.
Sales of Pharmaceuticals saw an increase
45.0% in 2017, from
6.27 billion Indian Rupees to 9.08 billion Indian Rupees.
Not all segments of Sequent Scientific Limited experienced an increase in sales in 2017:
sales of Analytical Services fell 16.3% to 65.99 million Indian Rupees.
(However, this segment's sales were only a very small portion of the company's overall sales).